...
首页> 外文期刊>Eating and weight disorders: EWD >A systematic review of studies on the faecal microbiota in anorexia nervosa: future research may need to include microbiota from the small intestine
【24h】

A systematic review of studies on the faecal microbiota in anorexia nervosa: future research may need to include microbiota from the small intestine

机译:对厌食症神经症粪便微生物群的研究的系统审查:未来的研究可能需要包括小肠的微生物群

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose Anorexia nervosa (AN) is a poorly understood and often chronic condition. Deviations in the gut microbiota have been reported to influence the gut–brain axis in other disorders. Therefore, if present in AN, it may impact on symptoms and illness progression. A review of the gut microbiota studies in AN is presented. Method A literature search on PubMed yielded 27 articles; 14 were selected and based on relevance, 9 articles were included. The findings were interpreted in the larger context of preclinical research and clinical observations. Results 8 out of 9 included studies analysed microbiota from faeces samples, while the last analysed a protein in plasma produced by the gut. Two studies were longitudinal and included an intervention (i.e., weight restoration), five were cross-sectional, one was a case report, and the last was a case series consisting of three cases. Deviations in abundance, diversity, and microbial composition of the faecal microbiota in AN were found. Conclusion There are currently only a few studies on the gut microbiota in AN, all done on faeces samples, and not all describe the microbiota at the species level extensively. The Archaeon Methanobrevibacter smithii was increased in participants with a BMI
机译:目的,厌食症(AN)是一种明白和往往慢性病的难度。据报道,肠道微生物群中的偏差会影响其他疾病中的肠脑轴。因此,如果存在,它可能会影响症状和疾病进展。提出了对肠道微生物群研究的综述。方法在Pubmed的文献搜索产生的27篇文章; 14被选中并基于相关性,包括9条制品。在临床前研究和临床观察的较大背景下,调查结果被解释。结果8分之一包括从粪便样品分析微生物群,而最后分析了由肠道产生的血浆中的蛋白质。两项研究是纵向的,包括干预(即,体重恢复),五个是横截面,一个是一个案例报告,最后是由三种病例组成的案例系列。发现粪便微生物群的丰富,多样性和微生物组成的偏差。结论目前只有少数关于肠道微生物群的一些研究,所有这些研究都在粪便样本上完成,并不完全描述在物种水平的微生物群。 Archaeon Methanobrevibacter Smithii在参与者中含有BMI <25在一项研究中,并在三项研究中特别是在患者中。如果检测到,Methanobrevibager Smithii可以成为未来研究的基准生物标志物。我们提出,也可以从小肠中收集微生物群样品,其中发生了营养素的主要交换,并且微生物群可能对AN产生生物影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号